Transgene Biotek Limited (TRABI.BO)
INR 7.34
(-0.53%)
INR 7.34
(-0.53%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 2.34 Million | 550.84 Thousand | 866.94 Thousand | 1.69 Million | 35.75 Thousand | 712.87 Thousand |
| Cost of Revenue | 4.04 Million | 663.16 Thousand | -462.13 Thousand | 608.28 Thousand | 147.87 Thousand | 338.52 Thousand |
| Gross Profit | -1.69 Million | -112.31 Thousand | 1.32 Million | 1.08 Million | -112.12 Thousand | 374.34 Thousand |
| Operating Expenses | 5.39 Million | 53.73 Million | 103.42 Million | 103.63 Million | 105.7 Million | 103.58 Million |
| Selling, General and Administrative Expenses | 5.39 Million | 1.21 Million | 1.16 Million | 1.75 Million | 2.19 Million | 1.57 Million |
| Research and Development Expenses | - | 48.51 Million | - | - | 263.36 Thousand | - |
| Other Expenses | - | 1.75 Million | 371.44 Thousand | 915.1 Thousand | 34.94 Thousand | 885.72 Thousand |
| Cost and Expenses | 9.43 Million | 54.4 Million | 102.96 Million | 104.24 Million | 105.84 Million | 103.91 Million |
| Operating Income | -7.08 Million | -60.02 Million | -103.87 Million | -104.35 Million | -107.6 Million | -105.77 Million |
| Interest Expense | 1.29 Million | 6.23 Million | 2.29 Million | 2.7 Million | 3.8 Million | 2.6 Million |
| Income Tax Expense | - | 6.17 Million | 2.14 Million | 2.71 Million | 1.79 Million | 2.72 Million |
| Earnings before Tax | -6.55 Million | -60.08 Million | -104.02 Million | -104.34 Million | -109.62 Million | -87.92 Million |
| Net Income | -6.55 Million | -60.08 Million | -104.02 Million | -104.34 Million | -109.62 Million | -87.92 Million |
| Earnings Per Share Basic | -0.09 | -0.79 | -1.37 | -1.38 | -1.45 | -1.16 |
| Earnings Per Share Diluted | -0.09 | -0.79 | -1.37 | -1.38 | -1.45 | -1.16 |
| Weighted Average Shares Outstanding | 72.83 Million | 75.77 Million | 75.77 Million | 75.77 Million | 75.77 Million | 75.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 72.83 Million | 75.77 Million | 75.77 Million | 75.77 Million | 75.77 Million | 75.77 Million |
| Gross Margin | -0.72 | -0.20 | 1.53 | 0.64 | -3.14 | 0.53 |
| EBIT Margin | -1.85 | -7.90 | -2.87 | -1.51 | -191.45 | -5.77 |
| Profit Margin | -2.79 | -109.08 | -119.98 | -61.54 | -3066.02 | -123.34 |
| EBITDA | -4.33 Million | -8.77 Million | -2.5 Million | -2.6 Million | -6.84 Million | 13.54 Million |
| Earnings Before Tax Margin | -3.02 | -108.97 | -119.82 | -61.55 | -3009.60 | -148.38 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 492 Thousand | 2.34 Million | 450 Thousand | 450 Thousand | 450 Thousand | 998.71 Thousand |
| Cost of Revenue | - | 4.04 Million | 1 Million | 998 Thousand | 1440.00 | 3180.00 |
| Gross Profit | 492 Thousand | -1.69 Million | -550 Thousand | -548 Thousand | 448.56 Thousand | 995.53 Thousand |
| Operating Expenses | 4.61 Million | 5.39 Million | 2.36 Million | 758 Thousand | 1.88 Million | 2.5 Million |
| Selling, General and Administrative Expenses | 4.61 Million | - | 2.33 Million | 758 Thousand | 865.93 Thousand | 671.27 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 6.51 Million | 1.82 Million | -22 Thousand | 438 Thousand | 438.47 Thousand | 438.47 Thousand |
| Cost and Expenses | 4.84 Million | 9.43 Million | 3.36 Million | 1.75 Million | 1.89 Million | 2.5 Million |
| Operating Income | -4.35 Million | -7.08 Million | -2.91 Million | -1.3 Million | -1.44 Million | -1.5 Million |
| Interest Expense | 173 Thousand | 1.29 Million | 322 Thousand | 323 Thousand | 322.83 Thousand | 322.83 Thousand |
| Income Tax Expense | - | 755.1 Thousand | 187.18 Thousand | 270.58 Thousand | 438.47 Thousand | 438.47 Thousand |
| Earnings before Tax | 1.99 Million | -6.55 Million | -2.72 Million | -1.19 Million | -1.32 Million | -1.38 Million |
| Net Income | 1.99 Million | -6.55 Million | -2.72 Million | -1.19 Million | -1.32 Million | -1.38 Million |
| Earnings Per Share Basic | 0.03 | - | -0.04 | -0.02 | -0.02 | -0.02 |
| Earnings Per Share Diluted | 0.03 | - | -0.04 | -0.02 | -0.02 | -0.02 |
| Weighted Average Shares Outstanding | 75.77 Million | 72.83 Million | 75.77 Million | 75.77 Million | 75.77 Million | 75.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.77 Million | 72.83 Million | 75.77 Million | 75.77 Million | 75.77 Million | 75.77 Million |
| Gross Margin | 1.00 | -0.72 | -1.22 | -1.22 | 1.00 | 1.00 |
| EBIT Margin | -8.37 | - | -5.96 | -2.39 | -1.72 | -0.84 |
| Profit Margin | 4.05 | -2.79 | -6.05 | -2.65 | -2.95 | -1.39 |
| EBITDA | -4.12 Million | - | -2.68 Million | -1.07 Million | -772.08 Thousand | -835.03 Thousand |
| Earnings Before Tax Margin | -8.85 | -3.02 | -6.47 | -2.90 | -3.20 | -1.51 |
SHYAMTEL
FMOCF
KIMS
TBR
JSE
NICL